Delivery Order SPE2DB20D2014-SPE2DB24FB52R
Award Date 4/4/24
Potential Completion Date 4/5/24
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $8,776.50 and a period of performance through January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical supply item. The contract has a ceiling value of $3,746.05 and is a firm fixed-price delivery order with a completion date of June 10, 2025. The contract is not set-aside and is open to full and open competition. Amerisourcebergen Drug Corp is the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTIHANCE 529 MG/ML VIAL 10ML. The $2,609.26 firm fixed-price contract has a completion date of June 28, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,122.32, is for the delivery of Multihance 529 mg/ml vial (10 ml). The order has a completion date of September 13, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical for providing a comprehensive range of pharmaceutical...
- This federal contract award is for the delivery of MULTIHANCE 529 MG/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,541.00 and an ultimate completion date of July 27, 2023. This delivery order contract is a firm fixed-price arrangement. The contract was awarded on July 26,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Multihance 529mg/ml. The delivery order, valued at $5,323.05, has a firm fixed price and an ultimate completion date of March 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,989.50 firm fixed-price Delivery Order, awarded on November 8, 2022, is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a medical product. The contract has an ultimate completion date of November 9, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML medical products. The contract, valued at $6,100.40, is a firm fixed-price delivery order with a completion date of September 6, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This delivery order, valued at $11,702.00, was awarded to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Multihance 529 mg/mL vial 20 mL, a contrast agent used in medical imaging procedures. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 1, 2025. The award was made without set-aside designation through competitive procurement by the Defense Logistics Agency (DLA), with performance to be fulfilled from the vendor's Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,733.00 firm fixed price delivery order is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has a completion date of January 30, 2024 and was awarded on January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor...